AstraZeneca (NASDAQ: AZN) announced a $15 billion investment in China through 2030 to expand manufacturing and research and development operations ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE